CUE - Cue Biopharma, Inc.
0.8566
0.020 2.370%
Share volume: 142,529
Last Updated: 04-24-2025
Pharmaceutical Products/Pharmaceutical Preparations:
-0.11%
PREVIOUS CLOSE
CHG
CHG%
$0.84
0.02
0.02%
View ratios
| Fiscal Date | 03-31-2023 | 06-30-2023 | 09-30-2023 | 12-31-2023 | 03-31-2024 | 06-30-2024 | 09-30-2024 | |
|---|---|---|---|---|---|---|---|---|
| Fiscal Quarter | Q1 2023 | Q2 2023 | Q3 2023 | Q4 2023 | Q1 2024 | Q2 2024 | Q3 2024 | |
| Report Date | 05-09-2023 | 08-08-2023 | 11-03-2023 | 03-28-2024 | 05-09-2024 | 08-14-2024 | 11-14-2024 | |
| Assets | ||||||||
| Total Assets | 81.682 M | 73.163 M | 68.888 M | 61.530 M | 53.951 M | 42.329 M | 44.810 M | |
| Current Assets | 68.755 M | 60.935 M | 57.517 M | 51.454 M | 44.669 M | 33.900 M | 37.256 M | |
| Inventories | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Other Current Assets | 2.360 M | 1.911 M | 1.165 M | 1.242 M | 0.000 | 0.000 | 0.000 | |
| Short Term Investments | 2.360 M | 1.911 M | 1.165 M | 1.242 M | 0.000 | 0.000 | 0.000 | |
| Total Receivables | 196.000 K | 1.135 M | 1.661 M | 1.698 M | 0.000 | 0.000 | 0.000 | |
| Current Cash | 66.199 M | 57.889 M | 54.691 M | 48.514 M | 41.029 M | 30.029 M | 32.420 M | |
| Total Non-current Assets | 12.927 M | 12.228 M | 11.371 M | 10.076 M | 0.000 | 0.000 | 0.000 | |
| Property Plant Equipment | 1.325 M | 1.192 M | 1.064 M | 795.000 K | 754.000 K | 667.000 K | 570.000 K | |
| Other Assets | 11.602 M | 10.886 M | 10.157 M | 9.130 M | 8.528 M | 7.762 M | 6.984 M | |
| Intangible Assets | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Goodwill | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Liabilities and shareholders’ equity | ||||||||
| Total Liabilities and shareholders’ equity | 81.682 M | 73.163 M | 68.888 M | 61.530 M | 53.951 M | 42.329 M | 44.810 M | |
| Total liabilities | 26.665 M | 27.159 M | 26.222 M | 24.445 M | 23.913 M | 20.707 M | 19.444 M | |
| Total current liabilities | 13.810 M | 16.307 M | 17.207 M | 17.081 M | 18.090 M | 16.459 M | 16.790 M | |
| Accounts Payable | 2.151 M | 2.356 M | 2.480 M | 3.501 M | 3.919 M | 3.906 M | 6.474 M | |
| Other liabilities | 445.000 K | 136.000 K | 0.000 | 0.000 | 2.579 M | 1.962 M | 1.326 M | |
| Current long term debt | 6.295 M | 7.328 M | 7.362 M | 7.331 M | 0.000 | 0.000 | 0.000 | |
| Long term debt | 12.410 M | 10.716 M | 9.015 M | 7.364 M | 3.244 M | 2.286 M | 1.328 M | |
| Other liabilities | 445.000 K | 136.000 K | 0.000 | 0.000 | 2.579 M | 1.962 M | 1.326 M | |
| Minority interest | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Total Shareholder equity | 55.017 M | 46.004 M | 42.666 M | 37.085 M | 30.038 M | 21.622 M | 25.366 M | |
| Common stock | 44.652 M | 44.799 M | 46.359 M | 47.210 M | 343.575 M | 345.330 M | 357.734 M | |
| Retained earnings | -263.565 M | -276.750 M | -287.755 M | -301.190 M | -313.537 M | -323.708 M | -332.368 M |
